Atrial fibrillation is a common abnormal type of heart rhythm that is considered one of the leading potential risk factors for stroke. If you have atrial fibrillation, preventative treatment can ...

The 500-patient Phase 3 trial (JX02002) met its primary endpoint, with a Kaplan Meier analysis shows a statistically significantly greater proportion of patients who self-administered etripamil ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and atrial fibrillation with rapid ventricular rate (AFib-RVR).

Atrial flutter and atrial fibrillation (AFib) are heart rhythm conditions that occur when the upper chambers of the heart (known as the atria) beat too quickly. Atrial flutter involves the atria ...

Premier Steven Miles has fast-tracked the appointment of a dedicated cross-border commissioner as young criminals run riot in a southern Queensland town. The southern border town of Goondiwindi ...

Fitbit recently added atrial fibrillation (AFib) notifications and irregular heart rhythm monitoring to a select number of its devices. But what is AFib, why is it important, and how can you use ...

Atrial flutter is closely related to atrial fibrillation but is not the same thing. The atria serve primarily as reservoirs for blood between heart contractions, whereas the ventricles are responsible ...

Milestone’s lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat ...

Milestone Pharmaceuticals is actively pursuing the development of etripamil, a self-administered nasal spray for patients with PSVT and AFib-RVR, conditions known for their episodic and symptomatic ...